Stunda-Zujeva A, Berele M, Lece A, esters A (2023) Comparison of antioxidant activity in various Spirulina containing products and factors affecting it
Early blood sugar fluctuations may cause hypoglycemia, which can feel like weakness, shakiness, and mental sluggishness
Ozempic (semaglutide), a GLP-1 receptor agonist approved for type 2 diabetes and widely prescribed off-label for weight loss, has been linked to serious gastrointestinal injuries including bowel obstruction and ileus , or intestinal paralysis
MOUNJARO represents an innovative therapeutic option for managing type 2 diabetes, with clinical trials demonstrating significant improvements in glycemic control and potential weight loss benefits
Patients on any oral antihyperglycemic agent in monotherapy (N=212) or on a PPAR agent in combination therapy (N=106) or not on an antihyperglycemic agent (off therapy for at least 8 weeks, N=34) were switched to monotherapy with pioglitazone (at a dose of 30-45 mg per day), and completed a run-in period of approximately 12 weeks in duration
No FDA-approved testosterone product exists for women in the United States, making compounding the only available route